Policy   Introductory Remarks by Dr. Mark Rohrbaugh List-of-Speakers Written Comments Received:   Senator Birch Bayh   Robert Huff, Editor GMHC Treatment Issues   Norman J. Latker, former Patent Counsel, HEW   John Erickson, President & CSO Sequoia Pharmaceuticals   Dan Ravicher, Executive Director, Public Patent Foundation   C. Peter Magrath et al, NASULGC, AAU and ACE   Carl E. Gulbrandsen, Managing Director WARF   Katharina Phillips, Council on Governmental Relations   Patricia Harsche Weeks, Immediate Past President AUTM   Joseph P. Allen, President NTTC   Heather L. Mason, V.P. Pharmaceutical Specialty Optns., Abbott Labs   Benjamin Young, OHHP   Lynda Dee, Co-Chair AIDS Treatment Activists Coalition   Julie Britton Haden, West Virginia Coalition for People with HIV/AIDS   Rhonda Connard & Amanda Lowther, Covenant House   Michael Weinstein, President AIDS Healthcare Foundation   Stephan E. Lawton, V.P. & General Counsel, BIO   David D. Ho, The Aaron Diamond AIDS Research Center   David Gollaher, California Health Care Institute   David Miller President iBioTM   David Halperin Attorney Counselor   James Love Pres. Essential Inventions Inc.   Jerome Reichman Duke Univ.

Note that this site uses cookies, Click here for more information.